Literature DB >> 23575274

A poor drug-resistant tuberculosis programme is worse than no programme: time for a change.

C-Y Chiang1, A Van Deun, D A Enarson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23575274     DOI： 10.5588/ijtld.12.0989

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  3 in total

1.  Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South Africa.

Authors:  Sizulu Moyo; Helen S Cox; Jennifer Hughes; Johnny Daniels; Leigh Synman; Virginia De Azevedo; Amir Shroufi; Vivian Cox; Gilles van Cutsem
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

2.  Western Pacific Regional Green Light Committee: progress and way forward.

Authors:  T Islam; B J Marais; N V Nhung; C-Y Chiang; W W Yew; T Yoshiyama; N R Mira; J van den Broek; R Lumb; N Nishikiori; L B Reichman
Journal:  Int J Infect Dis       Date:  2015-03       Impact factor: 3.623

3.  A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies.

Authors:  Edén M Rodríguez-Flores; Dulce Mata-Espinosa; Jorge Barrios-Payan; Brenda Marquina-Castillo; Mauricio Castañón-Arreola; Rogelio Hernández-Pando
Journal:  PLoS One       Date:  2019-05-30       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.